Navigation Links
Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
Date:2/26/2009

ed Parkinson's disease. Presently, apomorphine is administered by intermittent SC injection usually via a pre-filled autoinjector pen, or by continuous (waking day or round the clock) SC infusion. Drawbacks associated with SC therapy for patients and carers include the need for multiple injections, which can be painful and are often associated with the development of troublesome nodules at the injection site, and the requirement for a degree of manual dexterity that some PD patients find difficult. IN Apomorphine, an innovative aqueous nasal spray formulation has been designed to counter these issues by offering improvements in convenience and acceptability to both patients and physicians combined with ease/speed of use and rapid onset of action. Archimedes' unique formulation is based on enhanced solubility providing a stable, high strength solution, allowing a wide range of doses to be administered in a small spray volume using conventional, approved nasal spray devices.

Archimedes estimates that there around 1.3 million Parkinson's disease patients in the US and Europe, of which around 250,000 suffer from acute "off" episodes.

IN Diazepam - trial design, results and development rationale

A Phase I study in 12 healthy adult volunteers was conducted to assess the bioavailability, PK and safety/tolerability of a single 5 mg dose of Archimedes' IN Diazepam compared to commercially available intravenous (IV) and rectal formulations (2 mg and 5 mg doses respectively). Diazepam was extensively and rapidly absorbed from the IN product and demonstrated an enhanced bioavailability compared to the commercial rectal formulation, with maximum plasma concentrations achieved in approximately 15 minutes. The product was well tolerated and no clinically significant safety issues were reported. Rapid and reproducible delivery via the nasal route illustrates the potential of IN Diazepam to replace IV and rectal produ
'/>"/>

SOURCE Archimedes Pharma Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Adlyfe Strikes Translational Medicine Partnership With Wyeth Pharmaceuticals for Alzheimers Biomarker Assay
2. MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
3. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
4. Cordex Pharma Announces Strategic Master Services Equity Agreement With Cato BioVentures
5. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
6. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
7. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
8. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
9. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
10. Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments
11. Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical ... autoimmune diseases, asthma and allergic diseases, and cancer, today ... to its board of directors. "Yujiro,s ... a tremendous asset to our board," said Bassil ... Xencor. "Xencor faces a range of opportunities for our ...
(Date:7/30/2015)... 30, 2015  ResMed (NYSE: RMD ... definitive agreement to acquire Curative Medical, a ... sleep-disordered breathing medical devices and accessories. ... with ResMed,s global leadership in sleep and respiratory medicine, ... China suffering from sleep-disordered breathing ...
(Date:7/30/2015)... we bring you a special edition of #MedicareMonday on Medicare,s 50 th anniversary. ... Medicare resources and continue highlighting the success of the prescription drug benefit, commonly referred ... out our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
Breaking Medicine Technology:Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3
... -- URINOZINC® Prostate Formula Added to GNC Live ... The original, patented, URINOZINC® Prostate Formula ... Well stores and at select GNC franchise stores. ... stores spread over 49 countries worldwide. URINOZINC® is ...
... LONDON, June 14, 2011 MGT Capital Investments, Inc. (NYSE ... 8, 2011 it received notice from the NYSE Amex (the ... following Exchange continued listing standards:  Section 1003(a)(i) of the Company ... less than $2,000,000 and losses from continuing operations and/or net ...
Cached Medicine Technology:Patented URINOZINC® Prostate Formula Now Available at GNC Stores 2Patented URINOZINC® Prostate Formula Now Available at GNC Stores 3MGT Capital Investments Receives NYSE Amex Listing Deficiency Notification 2MGT Capital Investments Receives NYSE Amex Listing Deficiency Notification 3
(Date:8/1/2015)... ... August 01, 2015 , ... The condition where veins are enlarged ... women often causing pain and discomfort. Those who spend a lot of time on ... Houston Vein Center is doing what it can to create awareness and provide a ...
(Date:8/1/2015)... ME (PRWEB) , ... August 01, 2015 , ... Tina ... Retail Champions.” , Wilcoxson was given that honor by the National Retail Federation, the ... retail industry. Wilcoxson was one of three Maine business owners to be named as ...
(Date:8/1/2015)... ... August 01, 2015 , ... ... L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & Wellness (“Premier”) — ... portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy & Wellness ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, and Sam have ... the Apple AppStore. , The app is designed to track various metrics of ... tool to view personal health and use this information for positive behavior modification. Lume ...
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was featured ... latest and coolest applications on the market for iOS, Android, and Windows. Joe Toohey, ... viewers allows users to clarify, edit and delete any message including ones already sent. ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Local Retail Advocate Wins National Recognition 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2
... the Moores UCSD Cancer Center and the Arizona Oncology Services ... the Strut-Adjusted Volume Implant (SAVI) controls the rate of cancer ... brachytherapy. This study also demonstrates the accuracy and flexibility of ... and minimize the exposure of healthy surrounding tissue and organs. ...
... N.J. (July 12, 2010) A new study by ... University Medical Center sheds light on how bortezomib (VELCADE), ... known as proteasome inhibitors, works in mantle cell lymphoma. ... might benefit most from bortezomib. Additionally, researchers demonstrate that ...
... 2010 In an effort that will contribute ... Philippines and surrounding regions, the Laboratory Services Division ... (FDA) has attained the internationally recognized accreditation for ... International Electrotechnical Commission (ISO/IEC) 17025:2005. The FDA celebrates ...
... LANSING, Mich., July 12, 2010 Drinking tart cherry juice ... spent awake after going to sleep, according to a new ... 1 . A team of University of Pennsylvania, University ... pilot study on the sleep habits of 15 older adults. ...
... Starting in February 2011, Springer will publish a new ... . Focusing exclusively on translational aspects of drug ... for publication of high-quality research. It is an ... Drug Delivery and Translational Research will publish ...
... Mass. -- A subtle mutation affecting the epigenome - a ... lead to an inherited form of mental retardation that affects ... also involves cleft lip or cleft palate, appears to hinge ... offer several potential drug targets. The study, published online ...
Cached Medicine News:Health News:Radiation device allows for targeted breast radiation to control cancer 2Health News:Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma 2Health News:Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma 3Health News:Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma 4Health News:Medicine quality in Philippines and region strengthened with Philippine FDA's accreditation 2Health News:New study suggests tart cherry juice can be a natural solution for insomnia 2Health News:Springer launches Drug Delivery and Translational Research 2Health News:Study implicates new epigenetic player in mental retardation and facial birth defects 2Health News:Study implicates new epigenetic player in mental retardation and facial birth defects 3
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
The perfect tool to prepare for in-service or licensing exams, for recertification, or for use as a clinical refresher....
... TruFlow™ Oxygen flowmeter with a Lexan®inner calibrated ... calibration and manufacturing defects. A wide range ... needs. Also available with all popular inlet ... and double unit configurations. Our extra large ...
... Oxygen flowmeter with a Lexan®inner calibrated flow ... and manufacturing defects. A wide range of ... Also available with all popular inlet connections, ... double unit configurations. Our extra large knob ...
Medicine Products: